Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents
about
Structural integrity versus radiographic progression in rheumatoid arthritisAdiponectin and atherosclerosis in rheumatoid arthritisRemission in rheumatoid arthritis.Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritisPerformance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria.Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic riskOptimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study.Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort.Characteristics of rheumatoid arthritis in Algeria: a multicenter study.Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis.DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells.SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.
P2860
Q26777897-28AC32E3-7490-4BC1-9758-329FC7D5A63DQ33790971-3E545D69-C4AF-4050-8CB4-4C3D85334820Q34081946-2FB6E52C-9ABC-4E0C-8B75-15BAE55C961DQ34285092-DF114918-7558-40C8-BE38-6892E3DC1D28Q35126137-8ECBED92-9238-478E-8CA8-402850A89F19Q35249630-CE789CA5-E9CF-4C16-97C5-A3F8EFD2F9E0Q36830486-F38AB7B7-9535-47C3-A5F8-6C189363B971Q37010967-61B56509-F3CF-4C54-8964-FED0F660E197Q37691220-F2C8E0D4-2CA2-4BDF-BFF4-2E19791C7720Q38827554-D0CCAB6A-65EA-472B-A3E9-8E2B34B4E187Q39470609-FF0F5DE8-F2C8-428D-8B29-10F7A1D6D6A2Q41184418-13AD342A-18E1-40FC-AAA8-35C8459D668FQ45734541-09ABAC12-44F3-4E57-8B3D-0A2F72D6A8CCQ46167018-0AC25E2A-6FEC-4BF0-AD06-DA84874FB5A0Q51608422-ABC92C3F-A07C-4040-A9CA-DEEFFD5EDA54Q51673363-B406A713-E198-42AD-B84F-1032DB31839FQ55068670-1C39F31A-0FA9-4A8C-8615-ADD4BFAC0F6E
P2860
Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Disease activity level, remiss ...... , treated with anti-TNF agents
@ast
Disease activity level, remiss ...... , treated with anti-TNF agents
@en
type
label
Disease activity level, remiss ...... , treated with anti-TNF agents
@ast
Disease activity level, remiss ...... , treated with anti-TNF agents
@en
prefLabel
Disease activity level, remiss ...... , treated with anti-TNF agents
@ast
Disease activity level, remiss ...... , treated with anti-TNF agents
@en
P2093
P2860
P356
P1476
Disease activity level, remiss ...... , treated with anti-TNF agents
@en
P2093
Anders Gülfe
Daniel Aletaha
Pierre Geborek
Tore Saxne
P2860
P2888
P356
10.1186/1471-2474-10-41
P577
2009-04-23T00:00:00Z
P5875
P6179
1004169855